QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-is-co-diagnostics-stock-sinking-tuesday

Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns ab...

 co-diagnostics-announces-7m-registered-direct-offering-of-12727272-shares-at-a-price-of-055share

Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, p...

 d-boral-capital-maintains-buy-on-co-diagnostics-maintains-3-price-target

D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and maintains $3 price target.

 co-diagnostics-stock-is-rocketing-higher-monday-whats-going-on

Co-Diagnostics shares are trading higher Monday after the company signed a definitive agreement to establish CoMira Diagnostics.

 co-diagnostics-enters-equity-distribution-agreement-with-maxim-group-may-sell-common-stock-up-to-10m-from-time-to-time

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001692415/000149315225018591/form8-k.htm

 d-boral-capital-maintains-buy-on-co-diagnostics-maintains-3-price-target

D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and maintains $3 price target.

 d-boral-capital-maintains-buy-on-co-diagnostics-lowers-price-target-to-3

D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and lowers the price target from $1...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION